Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Cancer Research Communications
|
April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer
Michael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.
Nature Medicine
|
October 9, 2023
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Valsamo Anagnostou, Cheryl Ho, Garth Nicholas, et al.
Clinical Lung Cancer
|
February 28, 2019
Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol
Benjamin Levy, Luis Paz-Ares, Jaafar Bennouna, et al.
The Oncologist
|
August 16, 2022
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy
Melinda L Hsu, Joseph C Murray, Kevin J Psoter, et al.
Clinical Lung Cancer
|
April 30, 2019
Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer
Khinh Ranh Voong, Sarah Z Hazell, Wei Fu, et al.
Nature Medicine
|
January 26, 2023
Persistent mutation burden drives sustained anti-tumor immune responses
Noushin Niknafs, Archana Balan, Christopher Cherry, et al.
Cancer Research Communications
|
February 26, 2024
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC
Mari Nakazawa, Guilherme Harada, Paola Ghanem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 4, 2018
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
Karthik Suresh, Kevin J Psoter, Khinh Ranh Voong, et al.
JTO Clinical and Research Reports
|
November 8, 2021
Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
Joshua E Reuss, Emily Brigham, Kevin J Psoter, et al.
The Oncologist
|
September 5, 2024
Proceedings of the 1st biannual bridging the gaps in lung cancer conference
Narjust Florez, Sandip P Patel, Heather Wakelee, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Cancer Research Communications
|
April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer
Michael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.
Nature Medicine
|
October 9, 2023
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Valsamo Anagnostou, Cheryl Ho, Garth Nicholas, et al.
Clinical Lung Cancer
|
February 28, 2019
Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol
Benjamin Levy, Luis Paz-Ares, Jaafar Bennouna, et al.
The Oncologist
|
August 16, 2022
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy
Melinda L Hsu, Joseph C Murray, Kevin J Psoter, et al.
Clinical Lung Cancer
|
April 30, 2019
Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer
Khinh Ranh Voong, Sarah Z Hazell, Wei Fu, et al.
Nature Medicine
|
January 26, 2023
Persistent mutation burden drives sustained anti-tumor immune responses
Noushin Niknafs, Archana Balan, Christopher Cherry, et al.
Cancer Research Communications
|
February 26, 2024
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC
Mari Nakazawa, Guilherme Harada, Paola Ghanem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 4, 2018
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
Karthik Suresh, Kevin J Psoter, Khinh Ranh Voong, et al.
JTO Clinical and Research Reports
|
November 8, 2021
Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
Joshua E Reuss, Emily Brigham, Kevin J Psoter, et al.
The Oncologist
|
September 5, 2024
Proceedings of the 1st biannual bridging the gaps in lung cancer conference
Narjust Florez, Sandip P Patel, Heather Wakelee, et al.
Page
of 8